ارزیابی غلظت بیومارکر Pro-brain natriuretic peptide در بیماری دریچهای قلبی و تعیین شدت بیماری براساس آن در سگ

Boswood, A., Dakes-Mc Ewan J., Loureiro J.,James RA., Martin M., Stafford-Johnson M. Smith P. Little C. Attree S. (2008) The diagnosis accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract. 49: 26-39.

Ettinger, S.J.,  Feldmen, E.C. (2009) Text Book of Veterinary Internal Medicine, (7^th ed.) Saunders co. Missouri, USA.

Ettinger, S.J.,  Feldmen, E.C. (2009) Text Book of Veterinary Internal Medicine, (7^th ed.) Saunders co. Missouri, USA.

Ettinger, S.J.,  Feldmen, E.C. (2009) Text Book of Veterinary Internal Medicine. (7^th ed.) Saunders co. Missouri, USA.

Fine, D., Declue, A., Reinero, C. (2008)  Evaluation of circulating amino terminalpro-B-type natriuretic peptide concentration in dogs with respiratory distressattributable to congestive heart failure or primary pulmonary disease.J Am Vet Med Assoc. 232: 1674-1679.

Kellihan, H., Oyama, M., Reynolds, C., Stepien, R.L. (2009) Weekly variability of plasma and serum NT-proBNP measurments in normal dogs. J Vet Cardiol. 11: 93-97.

Maxi, M.G., Robinson, W.F. (2009) Myxomatous valvular degeneration (endocardiosis) in dogs, Jubb Kennedy and Palmer’s The Pathology of Domestic Animals. Edinburgh, (5^th ed.) Saunders Elsevier. Edinburgh, Scotland. p. 24–26.

Oyama, M., Sisson, D., Solter, P. (2007) Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriureticpeptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res. 68: 42-47.

Oyama, M., Reynolds, C. (2008) Biomarkers in the diagnosis of heart disease.Vet  Focus. 18: 1-4.

Oyama, M., Fox, P.R., Rush, J.E., Rozanski, E.A., Lesser, M. (2008) Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc. 232: 1496-1503.

Oyama, M., Rush, J.E., Rozanksi, E.A., Fox, P.R., Reynolds, C., Gordon, S.G. (2009) Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs. J Am Vet Med Assoc. 235: 1319-1325.

Paige, C.F., Abbott, J.A., Elvinger, F., Pyle, R.L. (2009) Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc. 234: 1398–1403.

Raffan, E., Loureiro, J., Dukes-McEwan, J., Fonfara, S., James, R., Swift, S., Bexfield, N., Herrtage, M.E., Archer, J. (2009) The Cardiac Biomarker NT-proBNP Is Increased in Dogs with Azotemia. J Vet Intern Med. 23: 1184–1189.

Reynolds, C., Brown, D.C., Oyama, M.A. (2008) Development of a multivariate statistical model to predict congestive heart failure in canine mitral valve disease. J Vet Intern Med. 22: 755.

Tarnow, I., Olsen, H., Kvort, C., Hoglund, K., Moesqaard, S.G., Kamstrup, T.S., Pederson, H.D., Haggstrom, J. (2009) Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J.180: 195-201.